TerrAscend Enters Into Amendment to the Membership Interest Purchase Agreement to Acquire Gage’s Licensed Operators and Extends Proxy Cut-Off for Voting at Special Meeting
Uncategorized November 10, 2021
Ryan Allway November 10th, 2021 Uncategorized Amendment is expected to facilitate and potentially expedite the timeframe in which the conditions for the closing of the Acquisition of Gage may be completed Deadlines to accept proxies and revocations extended to 12:00 p.m. (Eastern time) on the date of the special meeting, November 11,... Read more
Ryan Allway November 9th, 2021 Uncategorized Teen vaping of marijuana doubled between 2013 and 2020, according to a new study. In addition to harmful side effects, these trends are compounding problems that governments and businesses are already struggling with among the legal cannabis-consuming population. Fortunately, new technologies could be... Read more
Cannabis for Sleep: What is CBN?
CBDUncategorized October 6, 2021
According to a world sleep study, roughly 62% of the world’s population has issues getting a good night’s rest. Many people are turning to cannabis for help.
The post Cannabis for Sleep: What is CBN? appeared first on The Cannifornian.
Read more
Rapid Dose Therapeutics and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones
Uncategorized September 15, 2021
Ryan Allway September 15th, 2021 Uncategorized Pre-clinical testing has demonstrated manufacturing stability and statistically significant antibody production BURLINGTON, Ontario, September 15, 2021–(BUSINESS WIRE)–Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company“) (CSE: DOSE) and McMaster University (“McMaster“) are reporting a preliminary, yet significant milestone in the investigation of an... Read more
Ayr Wellness Announces 5% Share Buyback, the Maximum Allowed for CSE Listed Companies; Reaffirms 2022 Outlook
Uncategorized August 26, 2021
Ryan Allway August 26th, 2021 Uncategorized Ayr Announces Stock Repurchase Program of up to 5% of Subordinate Voting Shares – the maximum amount allowed for CSE listed companies Reiterates Guidance for 2022 of $800 Million in Revenue and $300 Million in Adjusted EBITDA1 Ayr’s Cash Balance as of June... Read more
Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms
TexasUncategorized August 19, 2021
Ryan Allway August 19th, 2021 Psychedelics, Uncategorized TORONTO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness ” or the “ Company ”) (CSE: SILO) (OTCQB: SILFF) (FRA: 3K70), a leading global psychedelics company, today announced a $3 million national distribution agreement with Texas-based distribution and advertising company One Light Enterprises... Read more
Silo Pharma Takes Next Step in Bringing Homing Peptide Tech to $30+ Billion RA Market
Uncategorized July 23, 2021
Ryan Allway July 23rd, 2021 Psychedelics, Top Story, Uncategorized Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease that causes painful swelling in joints in the hands, wrists, and knees. While medications can slow the disease and prevent joint deformity, there is no cure for the condition, and... Read more
Ryan Allway May 28th, 2021 Uncategorized High Tide becomes the first major publicly traded cannabis retailer to announce it has been approved to trade on Nasdaq. High Tide shares expected to begin trading on Nasdaq on June 2nd, 2021 High Tide has received approval from Nasdaq to list its... Read more
Algernon Pharmaceuticals Highlights New Animal Study Showing Effectiveness of Psychedelic Drug DMT in Treatment of Stroke
Uncategorized May 27, 2021
Ryan Allway May 27th, 2021 Uncategorized VANCOUVER, British Columbia, May 27, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) is pleased to highlight an independent research study from the University of Szeged in Hungary describing the use of N,N-dimethyltryptamine (“DMT”)... Read more
Ryan Allway May 10th, 2021 Psychedelics, Uncategorized San Diego, California–(Newsfile Corp. – May 10, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) (“Tryp”), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced today a master service agreement with Clinlogix, a Contract Research Organization (CRO),... Read more
